Sign in
Taking people in United StatesNo phase

Collects samples and data from people with amyloid diseases

Stores blood, urine and tissue samples from adults with amyloid diseases for future study.

Key facts

Who runs it
Boston Medical Center
Where
Boston, United StatesSee the site
Trial code
Registry title
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Status
Recruiting
People taking part
10,000 people, planned
Started
Jan 2000
Expected to end
Dec 2040
Type of study
Observational
Treatments tested
  • clonality analysis
  • polymerase chain reaction
  • protein analysis
  • biologic sample preservation procedure
  • laboratory biomarker analysis
  • fluorescence spectroscopy
  • quality-of-life assessment
Record updated
1 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have amyloidosis or may have it, and who were referred to the Amyloid Treatment and Research Center at Boston University Medical Center. Samples and data are collected for future research.

Age
18 Years and older
Sex
Men and women
Disease stage
Diagnosis or suspicion of amyloidosis

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • DISEASE CHARACTERISTICS:
  • Diagnosis or suspicion of amyloidosis; PATIENT CHARACTERISTICS:
  • Referred to the Amyloid Treatment and Research Center at Boston University Medical Center; PRIOR CONCURRENT THERAPY:
  • Not specified

Who cannot take part

  • None

Where in United States

  • Boston University Cancer Research CenterBoston, United StatesContact: Clinical Trials Office - Boston University Cancer Research CenTaking people

About the trial

What the trial wants to find out

RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future.

Read full original descriptionShow less

PURPOSE: This research study is collecting samples from patients with amyloid diseases

Treatments tested

  • clonality analysis
  • polymerase chain reaction
  • protein analysis
  • biologic sample preservation procedure
  • laboratory biomarker analysis
  • fluorescence spectroscopy
  • quality-of-life assessment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Data, Tissue, Blood, and Urine Repository for Amyloid Diseases
Plain-language title
Collects samples and data from people with amyloid diseasesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
1 December 2025